Attention small and medium-sized companies: Have you registered for Dancing with Venture yet? This exclusive event for NIIMBL member small and medium-sized companies gives you the chance to showcase your technology to venture capitalists who invest in the #lifesciences industry. Plus you won't want to miss a special the opening "De-risking Cash for Companies and Their Founders" session with speakers from Morgan Stanley. Learn more and register: https://lnkd.in/e8_bnHvF #biotech #venturecapital #biotechnology #science #pharma #biopharma
NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals’ Post
More Relevant Posts
-
We are gearing up to participate in the highly-anticipated Biotechnology Innovation Organization’s CEO & Investor Conference next week in New York. As one of the largest gatherings of leaders in biotech, this conference brings together institutional investors, industry analysts, and senior executives who play a pivotal role in shaping the future investment landscape of #biotechnology. Curious about how our services can propel you toward your next milestone? Don't miss this golden opportunity to connect with us! Feel free to request a meeting with our team by dropping an email to partner@benchinternational.com. For more information about the event, check out the details here: https://bcic.bio.org/ #BioCEO24 #BIOevents #RegulatoryAffairs #PharmaEvents #Partnering #BioTech #ExecutiveRecruiting #FutureofHealthcare #lifesciences
-
Great analysis by the folks at BDO of where the market stands. Here's to hoping! Reminder if you are looking for any fractional or full time support in accounting and finance reach out and lets talk.
After a slow period, biotech IPOs are on the rise in 2024, signaling a potential market thaw. Find out which factors are driving this resurgence in our Spring 2024 Biotech Brief: https://bit.ly/4b9xLXv #LifeSciences #Biotech
-
-
Here is a FREE comprehensive analysis on a biotech company, publicly traded on the NASDAQ stock exchange. BioTech Insights aims to provide understanding to those who wish to invest into the biotech market. View our 18 page, in-depth report below, and gain better insight like never before! #investing #biotech #marketresearch #finance #financialanalysis #machinelearning
-
After a slow period, biotech IPOs are on the rise in 2024, signaling a potential market thaw. Find out which factors are driving this resurgence in our Spring 2024 Biotech Brief: https://bit.ly/4b9xLXv #LifeSciences #Biotech
-
-
Check out an article written by my awesome colleagues Frank Rahmani, Carlton Fleming, and Istvan Hajdu about rebounding biotech transactions, "A Light at the End of the Tunnel: Rebounding Biotech Transactions Provide Hope for Life Sciences Companies" #biotech #biotechnology https://lnkd.in/g5UBtMHt
A Light at the End of the Tunnel: Rebounding Biotech Transactions Provide Hope for Life Sciences Companies | The Recorder
law.com
-
🚀 Trinity Biotech Stock Rated "Buy" Amid Price Fluctuations 📊 Exciting news! Trinity Biotech plc has just received a "buy" rating from StockNews.com analysts. This rating highlights potential investment opportunities around their innovative diagnostic products. 🔬💡 #Investment #StockMarket #Biotechnology #FinancialNews #Investor #StockTrading #TechStocks #MarketTrends https://lnkd.in/duxs9TDh
-
-
Join me at the BIO CEO & Investor Conference - one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. #bioceo24
-
Join me at the BIO CEO & Investor Conference - one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. #bioceo24
-
Join me at the BIO CEO & Investor Conference - one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. #bioceo24
-
-
Q1 in biotech shows promising trends with increased activity in PIPEs and follow-ons, signaling a robust start to the year. IPOs are also on the rise, marking a notable comeback in the sector. For more, please see this article in Endpoints News: https://bit.ly/4aBmAas #Biotech #IPOs #DealTransactions #InvestmentTrends
